Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 11, 2021, titled "Glenmark launches Tavulus�� for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler".